- Record: found
- Abstract: not found
- Article: not found
GlaxoSmithKline receives conditional marketing authorization in the EU for Arzerra (ofatumumab)
2010
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.